Beth Israel Lahey Health Will Appoint Shorett as CEO
The current COO will take the lead of the 39,000-employee health system in January 2027.
Updated on Oct. 9, 2026 in People
Live Poll
Do you trust internal promotions more than outside hires to lead your local hospital system?
Beth Israel Lahey Health will transition to new leadership in January 2027, when current COO Peter Shorett succeeds outgoing CEO Kevin Tabb. The system, which serves 2.1 million patients, finalized the selection following a national board-led search.
Why it matters
As the state's healthcare landscape evolves, leadership transitions at major systems directly impact regional clinical strategy and operational integration. Shorett will oversee the integration of cancer care with Dana-Farber, a move that will shift the competitive dynamics for specialized services in the Longwood Medical Area.
The system currently employs 39,000 people and serves 2.1 million patients across Eastern Massachusetts and Southern New Hampshire. These figures provide the scale for the upcoming leadership transition.
The players
Peter Shorett
The current COO of Beth Israel Lahey Health who will become president and CEO in January 2027.
Kevin Tabb
The outgoing CEO of Beth Israel Lahey Health who announced his departure in March 2026.
Beth Israel Lahey Health
A major Massachusetts-based health system employing 39,000 workers and serving 2.1 million patients.
Dana-Farber
A prominent cancer care provider that will integrate services with Beth Israel Lahey Health.
The details
Peter Shorett, who joined the organization in 2019 following a tenure as a senior partner at Chartis, will move from his role as COO to the chief executive position. His primary strategic mandate will involve navigating the complex clinical integration of cancer services between Beth Israel Lahey Health and Dana-Farber. The transition follows a formal national search conducted by the board of directors.
Timeline
2019: Beth Israel Lahey Health formed and Peter Shorett joined the organization.
March 2026: Kevin Tabb announced his plan to step down as CEO.
January 2027: Peter Shorett will officially begin his tenure as CEO.
Market Landscape
This leadership transition marks the first CEO change for the system since its 2019 formation. The shift underscores the ongoing consolidation and integration of specialized cancer care services among major regional healthcare providers.
Operators in the regional healthcare supply and clinical service sectors should monitor upcoming changes to the system's procurement and care-integration priorities. Expect the shift in leadership to influence partnership requirements as the organization streamlines its clinical offerings.
The takeaway
The upcoming transition signals a strategic pivot toward complex service-line integration in the competitive Longwood Medical Area. Operators should monitor the new CEO's progress in aligning the Beth Israel Lahey Health and Dana-Farber cancer care operations through late 2026.
Further reading
For more updates on regional leadership shifts, visit the People section.
Live Poll
Do you trust internal promotions more than outside hires to lead your local hospital system?
